Measurement of MHC/peptide interactions by gel filtration.
about
A Protective Role for Dengue Virus-Specific CD8+ T CellsDrug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireStructure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicityT-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsAcyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.IMMUNOCAT-a data management system for epitope mapping studiesPeptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles.Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinityIdentification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082:01 (Mane A*0301).Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101.Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype.The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infectionIdentification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.State of the art and challenges in sequence based T-cell epitope predictionBroad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restriFunctional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities.Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 miceAutomated benchmarking of peptide-MHC class I binding predictions.Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 miceThe identification of potentially pathogenic and therapeutic epitopes from common human allergens.A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general populationIdentification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humansMutated BCR-ABL generates immunogenic T-cell epitopes in CML patientsAdjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondiiPreventing tumor escape by targeting a post-proteasomal trimming independent epitope.T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome.Spleen cells from young but not old immunized mice eradicate large established cancers.Prediction of epitopes using neural network based methods.
P2860
Q27488347-653CD52C-BFBD-4EB4-9CC6-F2CFE843BC70Q27679355-A1AE4ADE-6D03-466A-9C6F-24869928C603Q27680213-0B77C510-D41D-4655-8F7A-3AC431412C6FQ28485408-474E9DC5-FAFA-4AA9-BD8D-982AF0C06B1BQ28547607-7838F02E-5EC0-48E6-82D5-8E9D6E070861Q28752157-97C786CD-5CBC-4C71-891E-EF863EBF1D10Q30413358-F9404851-C184-4C9A-BF6B-4A84E1272D72Q30413827-4CC6DE44-8F68-4FDC-ACBB-EC1096B466CDQ30419031-4EF36FBD-09AD-4ECF-8071-4B874C0672F9Q33459720-666C7101-6014-43A4-9F2D-AD9223D3AC09Q33557772-ACA56BBB-21F7-45CE-8377-A494F8229B6BQ33651342-F24A10AB-FF50-43D5-B9A6-8C2B815541C5Q33676647-3721226D-9F0F-48CF-B63A-20289D9604BDQ33851329-EC2138B3-C3E5-4EE9-A133-0C9106C5A133Q33917224-89224CB6-6EA8-4C9F-B91C-06BDCDFAFA57Q33931464-AB675A9B-8D97-4B0D-8BC3-C1924DE664D2Q33952695-BAD04ED8-3D90-4873-8ACD-413E6531ACF9Q33956199-A5CF67A4-D0A2-498A-AF28-04C1AF6A4AABQ34057942-171CC026-2BDD-4205-86FC-FC8BE47BF14AQ34312500-09E22C29-748C-4854-8113-6545277AE670Q34428561-A0282B82-D165-4C3D-9325-08C24A3BDBDAQ34439215-4F3A7C6D-C720-4EA6-8DB8-9C645C832BEDQ34744724-C24568E6-D355-4B56-8379-80D29B7DF048Q35018972-4247493B-4B60-41F2-BA1D-3CF2C3D657FCQ35268996-4606D170-EB91-4029-BA6B-ADC2AEACE097Q35634197-8BB425D7-5EA4-44D6-B21B-92C7FBBBF31FQ35785418-0A7E68CA-E9BC-4B9E-920F-45659B2BDD19Q35835769-4F2E29C4-4DF8-4375-B633-FECDF33D0CC2Q35839141-BB748EC3-C267-4D80-9861-6646EBD29C05Q35840599-1FAC2D7E-D0E8-4CA2-88C2-FF746FFA7EFCQ36541082-21870436-4D29-4B3E-B90F-E03AFAA42D82Q36788055-E5F6FFB3-2B55-4809-93C0-09D10BA2A9B6Q36886232-F5A405C9-3B85-4824-82B6-70D0A7D1DF8CQ36994720-4447D939-5522-49E7-8684-A1CFFC1B4F66Q37139374-A1D9C3AB-AA1B-4A84-A260-8C6A006B4224Q37277042-6A6925E5-F670-4FA5-8987-16794355D6A3Q37346707-66C17B96-9FAC-40D3-BE1E-AFCD6EFF4F30Q37384380-DFF50E41-56BB-42BD-A876-85DF0C957257Q37706396-2F53EF30-A5AA-4D7B-9521-31DDC9CB785CQ37806810-B4E6E9D7-9C55-4AC0-9BE5-8376962A13FB
P2860
Measurement of MHC/peptide interactions by gel filtration.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Measurement of MHC/peptide interactions by gel filtration.
@en
Measurement of MHC/peptide interactions by gel filtration.
@nl
type
label
Measurement of MHC/peptide interactions by gel filtration.
@en
Measurement of MHC/peptide interactions by gel filtration.
@nl
prefLabel
Measurement of MHC/peptide interactions by gel filtration.
@en
Measurement of MHC/peptide interactions by gel filtration.
@nl
P2093
P2860
P1476
Measurement of MHC/peptide interactions by gel filtration.
@en
P2093
P2860
P304
P356
10.1002/0471142735.IM1803S31
P478
Chapter 18
P577
2001-05-01T00:00:00Z